Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

(2012) Kimberly E. Hanson et al.   PLoS One

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

(2011) Valerio Del Bono et al.   Clinical and Vaccine Immunology

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?

(2010) Konstantinos Leventakos et al.   CLINICAL INFECTIOUS DISEASES

Breakthrough Invasive Candidiasis in Patients on Micafungin

(2010) C. D. Pfeiffer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

(2009) Sophia Koo et al.   CLINICAL INFECTIOUS DISEASES